Gin Hwa Biotech (ROCO:7806) Total Assets: NT$1,107.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7806 Gin Hwa Biotech Inc ROCO:7806
22 GF Score
Price NT$61.90
! 2 Warning Signs
View Full Analysis

What is Gin Hwa Biotech Total Assets?

Gin Hwa Biotech ROCO:7806 22 Total Assets is NT$1,107.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Gin Hwa Biotech's Total Assets for the quarter that ended in Dec. 2025 was NT$1,107.0 Mil.

During the past 12 months, Gin Hwa Biotech's average Total Assets Growth Rate was 53.60% per year. During the past 3 years, the average Total Assets Growth Rate was 68.50% per year.

During the past 4 years, Gin Hwa Biotech's highest 3-Year average Total Assets Growth Rate was 68.50%. The lowest was 68.50%. And the median was 68.50%.

Total Assets is connected with ROA %. Gin Hwa Biotech's annualized ROA % for the quarter that ended in Dec. 2025 was 5.52%. Total Assets is also linked to Revenue through Asset Turnover. Gin Hwa Biotech's Asset Turnover for the quarter that ended in Dec. 2025 was 0.26.

Gin Hwa Biotech  (ROCO:7806) Total Assets Explanation

Total Assets is connected with ROA %.

Gin Hwa Biotech's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=54.828/( (877.742+1106.984)/ 2 )
=54.828/992.363
=5.52 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Gin Hwa Biotech's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=254.458/( (877.742+1106.984)/ 2 )
=254.458/992.363
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Gin Hwa Biotech Total Assets Related Terms

Gin Hwa Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for Gin Hwa Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gin Hwa Biotech Total Assets Chart

Gin Hwa Biotech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Assets
248.08 590.03 760.40 1,106.98

Gin Hwa Biotech Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial 590.03 611.05 760.40 877.74 1,106.98
ROCO:7806
22GF Score
Gin Hwa Biotech Inc ROCO:7806
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gin Hwa Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Gin Hwa Biotech's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=774.177+332.807
=1,107.0

Gin Hwa Biotech's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=774.177+332.807
=1,107.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$1,107.0 Mil mean?
Gin Hwa Biotech (ROCO:7806) has a Total Assets of NT$1,107.0 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Gin Hwa Biotech and its competitors.
Is Gin Hwa Biotech's Total Assets too high?
Gin Hwa Biotech's current Total Assets is NT$1,107.0 Mil. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's Total Assets compare to VRTX and REGN?
Gin Hwa Biotech's Total Assets of NT$1,107.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current Total Assets is NT$1,107.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current Total Assets of NT$1,107.0 Mil. The current Total Assets is NT$1,107.0 Mil. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current Total Assets is NT$1,107.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gin Hwa Biotech Business Description

Address No. 5, Guangming 7th Lane, Weixin Road, 1st Floor, Yong'an District, Kaohsiung, TWN, 828
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score

Get the complete analysis for ROCO:7806

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.90
Price